EFTR insider filings

eFFECTOR Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-13. Screen EFTR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EFTR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — eFFECTOR Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-06-134Harrington-Smith Kristen — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-06-134Bhatt Elizabeth — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-06-134Gallagher Brian M. Jr. — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-06-134Klencke Barbara — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-06-134Loewy Caroline M — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-06-134Ehrlich Christopher B — DirectorGrant/award (A): 800 (derivative) @ $0EDGAR
2024-05-174Byrnes Michael — Chief Financial OfficerGrant/award (A): 1,387 @ $1.68EDGAR
2024-05-174WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 1,806 @ $1.68EDGAR
2024-02-214Harrington-Smith Kristen — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214Warner Douglas J — Chief Medical OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-02-214Bhatt Elizabeth — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214Gallagher Brian M. Jr. — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214Klencke Barbara — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214Byrnes Michael — Chief Financial OfficerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-02-214Loewy Caroline M — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214Ehrlich Christopher B — DirectorGrant/award (A): 2,000 (derivative) @ $0EDGAR
2024-02-214WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2023-11-294SR ONE CAPITAL MANAGEMENT, LLC — 10% owner
SR One Capital Fund I Aggregator LP — 10% owner
SR ONE CAPITAL PARTNERS I, LP — 10% owner
SR One Co-Invest I, LLC — 10% owner
SR One Co-Invest I Manager, LLC — 10% owner
George Simeon — 10% owner
Sale (S): 430,578 @ $0.61 · Sale (S): 178,585 @ $0.61EDGAR
2023-11-164Byrnes Michael — Chief Financial OfficerGrant/award (A): 4,524 @ $0.50EDGAR
2023-11-164WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 5,979 @ $0.50EDGAR
2023-09-114Loewy Caroline M — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-08-144WORLAND STEPHEN T — Chief Executive Officer, DirectorOption exercise (M): 33,799 @ $0.52 · Option exercise (M): 33,799 (derivative) @ $0EDGAR
2023-06-224Harrington-Smith Kristen — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-224Bhatt Elizabeth — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-224Gallagher Brian M. Jr. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-224Klencke Barbara — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-224Smither John W — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-224Ehrlich Christopher B — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-05-164Byrnes Michael — Chief Financial OfficerGrant/award (A): 4,863 @ $0.46EDGAR
2023-05-164WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 6,401 @ $0.46EDGAR
2023-01-244Harrington-Smith Kristen — DirectorGrant/award (A): 28,125 (derivative) @ $0EDGAR
2023-01-244Bhatt Elizabeth — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-01-244Gallagher Brian M. Jr. — DirectorGrant/award (A): 50,938 (derivative) @ $0EDGAR
2023-01-244Klencke Barbara — DirectorGrant/award (A): 28,125 (derivative) @ $0EDGAR
2023-01-244Smither John W — DirectorGrant/award (A): 36,875 (derivative) @ $0EDGAR
2023-01-244Ehrlich Christopher B — DirectorGrant/award (A): 35,938 (derivative) @ $0EDGAR
2023-01-194Warner Douglas J — Chief Medical OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2023-01-194Gandhi Mayank — Chief Business OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-01-194Byrnes Michael — Chief Financial OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2023-01-194WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2022-11-164Byrnes Michael — Chief Financial OfficerGrant/award (A): 4,651 @ $0.47EDGAR
2022-11-164WORLAND STEPHEN T — Chief Executive Officer, DirectorGrant/award (A): 6,047 @ $0.47EDGAR
2022-10-064Ehrlich Christopher B — DirectorPurchase (P): 346 @ $0.57EDGAR
2022-09-284Gandhi Mayank — Chief Business OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-09-274Ehrlich Christopher B — DirectorPurchase (P): 18,867 @ $0.55EDGAR
2022-08-084Warner Douglas J — Chief Medical OfficerGrant/award (A): 618,160 (derivative) @ $0EDGAR
2022-08-034Presidio Management Group X LLC — 10% owner
US VENTURE PARTNERS X LP — 10% owner
USVP X AFFILIATES LP — 10% owner
Tansey Casey M — 10% owner
ROOT JONATHAN D — 10% owner
Sale (S): 25,896 @ $0.79 · Sale (S): 807 @ $0.79 · Sale (S): 27,348 @ $0.80 · Sale (S): 853 @ $0.80 · Sale (S): 57,580 @ $0.80 · Sale (S): 1,796 @ $0.80EDGAR
2022-07-294Presidio Management Group X LLC — 10% owner
US VENTURE PARTNERS X LP — 10% owner
USVP X AFFILIATES LP — 10% owner
Tansey Casey M — 10% owner
ROOT JONATHAN D — 10% owner
Sale (S): 31,533 @ $0.89 · Sale (S): 984 @ $0.89EDGAR
2022-07-274Presidio Management Group X LLC — 10% owner
US VENTURE PARTNERS X LP — 10% owner
USVP X AFFILIATES LP — 10% owner
Tansey Casey M — 10% owner
ROOT JONATHAN D — 10% owner
Sale (S): 2,210 @ $0.93 · Sale (S): 69 @ $0.93 · Sale (S): 2,691 @ $0.90 · Sale (S): 84 @ $0.90 · Sale (S): 42,344 @ $0.89 · Sale (S): 1,321 @ $0.89EDGAR
2022-07-224Presidio Management Group X LLC — 10% owner
US VENTURE PARTNERS X LP — 10% owner
USVP X AFFILIATES LP — 10% owner
Tansey Casey M — 10% owner
ROOT JONATHAN D — 10% owner
Sale (S): 9,726 @ $1.00 · Sale (S): 304 @ $1.00 · Sale (S): 2,584 @ $0.95 · Sale (S): 81 @ $0.96 · Sale (S): 7,383 @ $0.91 · Sale (S): 231 @ $0.91EDGAR

Recent 8-K events — eFFECTOR Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-06-268-K2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementEDGAR
2024-06-258-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-06-248-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-148-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-208-K8.01 — Other EventsEDGAR
2024-05-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-05-098-K/A1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-098-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.01 — Changes in Control of Registrant
EDGAR
2024-05-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-048-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EFTR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs